Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
Pharma
J&J looks to offload remaining Kenvue stake in $3.75B deal
J&J is again cutting its holdings in Kenvue. This time, it's pursuing a "debt-for-equity" offering that looks to be worth about $3.75 billion.
Eric Sagonowsky
May 13, 2024 9:04am
Novartis tops docs' ranking of heart disease drug makers
May 7, 2024 4:30pm
Kenvue plots hundreds of layoffs as J&J service pact closes out
May 7, 2024 11:26am
J&J nears sweeping resolution to long-standing talc litigation
May 1, 2024 10:55am
100 not out: J&J celebrates UK centenary with new name and look
May 1, 2024 3:00am
J&J, BMS set to appeal losses in IRA drug pricing lawsuits
Apr 30, 2024 11:48am